3,6-Dimethoxy-4-methylpyridazine

Catalog No.: 
ACFNGW388
CAS No.: 
89943-29-3
Molecular Formula: 
C7H10N2O2
Molecular Weight: 
154.17
3,6-Dimethoxy-4-methylpyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$291.00InquiryInquiry
1g97%$874.00InquiryInquiry
5g97%$3144.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6-Dimethoxy-4-methylpyridazine
IUPAC Name3,6-dimethoxy-4-methylpyridazine
MDL No.MFCD09959871
Molecular FormulaC7H10N2O2
Molecular Weight154.17
SMILESCC1=CC(OC)=NN=C1OC
InChI KeyFODLXNPPUWRDEJ-UHFFFAOYSA-N
Synonym3,6-Dimethoxy-4-methylpyridazine;Pyridazine, 3,6-dimethoxy-4-methyl-
CAS No.89943-29-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFNGW388 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  4. Then
  5. ACFNGW388 route product structure diagram
    ACFNGW38889943-29-3
Inquiry

2. ACFNGW388 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFNGW388 route product structure diagram
    ACFNGW38889943-29-3
Inquiry

3. ACFNGW388 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFNGW388 route product structure diagram
    ACFNGW38889943-29-3
Inquiry

Comments (0)